Molecular Templates to Present at the 2017 BIO Inv

AUSTIN, Texas, Oct. 06, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the 2017 BIO Investor Forum, being held October 17-18 in San Francisco, California.

BIO Investor Forum Date:               Tuesday, October 17 Time:               10:30am Pacific Time Location:          Westin St. Francis, San Francisco, Elizabethan C Ballroom Webcast:           http://www.veracast.com/webcasts/bio/investor...335172.cfm

About Molecular Templates  Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.  For additional information, please visit Molecular Templates’ website at ​ www.mtem.com ​.

Investor Contact: Andrew McDonald, Ph.D. andrew@lifesciadvisors.com 646-597-6987